These data indicate that the compensatory increase in P-Akt expression seen in AICAR-treated ALL cells results from both activation of IRS-1 by AMPK, and inhibition of the mTOR mediated feedback loop inhibition of IRS-1 activity. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.